Dineshkumar Haribhau Dandekar

Dineshkumar Haribhau Dandekar

Active Director Additional Director DIN 08844683
DIN 08844683 First appointment Aug 2020 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Aug 2020
Shareholding value •••• Premium profile

About Dineshkumar Haribhau Dandekar

Data last updated:

Dineshkumar Haribhau Dandekar has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Incorporeal Pharma Private Limited and Amogha Bio Solutions Private Limited. Formerly with 1 company, such as Resinno Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹98.2 Lakh; the largest is Incorporeal Pharma Private Limited at ₹98.2 Lakh (FY 2025).

DIN 08844683
Primary Designation Additional Director
First Appointment 23 Aug 2020
Oldest Company Age 6 yrs
Largest company Incorporeal Pharma Private Limited · ₹98.2 Lakh (FY 2025)
Combined revenue ₹98.2 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Incorporeal Pharma Private Limited U51909PN2021PTC205424
Additional Director06 Dec 20222021₹98.2 Lakh (FY 2025)Active
Amogha Bio Solutions Private Limited U73100MH2020PTC344318
Director23 Aug 20202020₹3,543 (FY 2022)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Resinno Biotech Private Limited U85320MH2018PTC304666
Director31 Aug 20212018₹45.1 Lakh (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Incorporeal Pharma Private Limited
Amogha Bio Solutions Private Limited
Resinno Biotech Private Limited
Premium access

Shareholding and investment profile for Dineshkumar Haribhau Dandekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dineshkumar Haribhau Dandekar

Dineshkumar Haribhau Dandekar has 6 years in corporate governance. Holds Additional Director and Director roles. Currently with 2 companies, including Incorporeal Pharma Private Limited and Amogha Bio Solutions Private Limited. Formerly with 1 company, such as Resinno Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹98.2 Lakh; the largest is Incorporeal Pharma Private Limited at ₹98.2 Lakh (FY 2025).

Dineshkumar Haribhau Dandekar is associated with 2 companies as Additional Director and Director, including Incorporeal Pharma Private Limited (₹98.2 Lakh), Amogha Bio Solutions Private Limited (₹3,543).

Dineshkumar Haribhau Dandekar has expertise in General Business, Technology.

Dineshkumar Haribhau Dandekar has 6 years in corporate governance.

By reported revenue, the largest current company of Dineshkumar Haribhau Dandekar is Incorporeal Pharma Private Limited, with revenue of ₹98.2 Lakh (FY 2025).

The 2 current companies of Dineshkumar Haribhau Dandekar that report revenue have a combined latest revenue of ₹98.2 Lakh.

Dineshkumar Haribhau Dandekar currently holds positions at 2 companies: Incorporeal Pharma Private Limited (₹98.2 Lakh), Amogha Bio Solutions Private Limited (₹3,543).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available